Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAHOR for Dyslipidaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where TAHOR was used for Dyslipidaemia.

Most Reported Side Effects for TAHOR

Side Effect Reports % Deaths Hosp.
Hepatocellular injury 11 8.9% 0 8
Rhabdomyolysis 11 8.9% 2 10
Cholestasis 9 7.3% 0 5
Renal failure 8 6.5% 1 7
Thrombocytopenia 8 6.5% 4 6
Drug reaction with eosinophilia and systemic symptoms 6 4.8% 0 6
Inflammation 6 4.8% 0 3
Lung disorder 6 4.8% 3 6
Pancytopenia 6 4.8% 0 6
Weight decreased 6 4.8% 0 1
Abdominal pain upper 5 4.0% 0 4
Diarrhoea 5 4.0% 0 1
Interstitial lung disease 5 4.0% 2 4

Other Indications for TAHOR

Product used for unknown indication (31) Hypercholesterolaemia (11)

Other Drugs Used for Dyslipidaemia

ATORVASTATIN (4,796) ROSUVASTATIN (2,032) SIMVASTATIN (1,253) EVOLOCUMAB (1,056) EZETIMIBE (787) PRAVASTATIN (747) FENOFIBRATE (606) EZETIMIBE\SIMVASTATIN (302) ATORVASTATIN\EZETIMIBE (239) DEVICE (172)

Related Pages

TAHOR Full Profile All Dyslipidaemia Drugs TAHOR Demographics TAHOR Timeline